[Seite 94↓]


1. Acquaviva C, Ferrara P, Bossis G, Brockly F, Salvat C, Jariel-Encontre I, Piechaczyk M: Degradation of cellular and viral Fos proteins. Biochimie. 2001, 83 (3-4), S. 357-62.

2. Adams JW, Migita DS, Yu MK, Young R, Hellickson MS, Castro-Vargas FE, Domingo JD, Lee PH, Bui JS, Henderson SA: Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem. 1996, 271 (2), S. 1179-86.

3. Akopian TN, Kisselev AF, Goldberg AL: Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J Biol Chem. 1997, 272 (3), S. 1791-8.

4. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991, 1072 (2-3), S. 129-57.

5. Baumeister W, Dahlmann B, Hegerl R, Kopp F, Kuehn L, Pfeifer G: Electron microscopy and image analysis of the multicatalytic proteinase. FEBS Lett. 1988, 241 (1-2), S. 239-45.

6. Brown MG, Driscoll J, Monaco JJ: MHC-linked low-molecular mass polypeptide subunits define distinct subsets of proteasomes. Implications for divergent function among distinct proteasome subsets. J Immunol. 1993, 151 (3), S. 1193-204.

7. Bush KT, Goldberg AL, Nigam SK: Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem. 1997, 272 (14), S. 9086-92.

8. Calderone A, Takahashi N, Izzo NJ Jr, Thaik CM, Colucci WS: Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 1995, 92 (9), S. 2385-90.

[Seite 95↓]

9. Chu-Ping M, Slaughter CA, DeMartino GN: Purification and characterization of a protein inhibitor of the 20S proteasome (macropain). Biochim Biophys Acta. 1992, 1119 (3), S. 303-11.

10. Chu-Ping M, Vu JH, Proske RJ, Slaughter CA, DeMartino GN: Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. J Biol Chem. 1994, 269 (5), S. 3539-47.

11. Clark WA, Decker ML, Behnke-Barclay M, Janes DM, Decker RS: Cell contact as an independent factor modulating cardiac myocyte hypertrophy and survival in long-term primary culture. Mol Cell Cardiol. 1998, 30 (1), S. 139-55.

12. Coux O, Tanaka K, Goldberg AL: Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 1996, 65, S. 801-47.

13. Denhardt DT: Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J. 1996, 318 (Pt 3), S. 729-47.

14. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994, 76 (6), S. 1025-37.

15. Deveraux Q, Ustrell V, Pickart C, Rechsteiner M: A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem. 1994, 269 (10), S. 7059-61.

16. Drexler HC, Risau W, Konerding MA: Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J. 2000, 14 (1), S. 65-77.

17. Fan CM, Maniatis T: Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway. Nature. 1991, 354 (6352), S. 395-8.

18. Fedida D, Braun AP, Giles WR: Alpha 1-adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol Rev. 1993, 73 (2), S. 469-87.

[Seite 96↓]

19. Fenteany G, Standaert RF, Reichard GA, Corey EJ, Schreiber SL: A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc Natl Acad Sci. 1994, 91 (8), S. 3358-62.

20. Ferrell K, Wilkinson CR, Dubiel W, Gordon C: Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci. 2000, 25 (2), S. 83-8.

21. Fleming JA, Lightcap ES, Sadis S, Thoroddsen V, Bulawa CE, Blackman RK: Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. Proc Natl Acad Sci. 2002, 99 (3), S. 1461-6.

22. Früh K, Gossen M, Wang K, Bujard H, Peterson PA, Yang Y: Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 1994, 13 (14), S. 3236-44.

23. Glickman MH, Ciechanover A: The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002, 82 (2), S. 373-428.

24. Goldberg AL, Rock KL: Proteolysis, proteasomes and antigen presentationProteolysis, proteasomes and antigen presentation. Nature. 1992, 357 (6377), S. 375-9.

25. Guo GG, Gu M, Etlinger JD: 240-kDa proteasome inhibitor (CF-2) is identical to delta-aminolevulinic acid dehydratase. J Biol Chem. 1994, 269 (17), S. 12399-402.

26. Hanford DS, Thuerauf DJ, Murray SF, Glembotski CC: Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem. 1994, 269 (42), S. 26227-33.

[Seite 97↓]

27. Hannan RD, Luyken J, Rothblum LI: Regulation of rDNA transcription factors during cardiomyocyte hypertrophy induced by adrenergic agents. J Biol Chem. 1995, 270 (14), S. 8290-7.

28. Hannan RD, Rothblum LI: Regulation of ribosomal DNA transcription during neonatal cardiomyocyte hypertrophy. Cardiovasc Res. 1995, 30 (4), S. 501-10.

29. Harris KF, Shoji I, Cooper EM, Kumar S, Oda H, Howley PM: Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc Natl Acad Sci. 1999, 96 (24), S. 13738-43.

30. Hefti MA, Harder BA, Eppenberger HM, Schaub MC: Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1997, 29 (11), S. 2873-92.

31. Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem. 1998, 67, S. 425-79.

32. Hibi M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993, 7 (11), S. 2135-48.

33. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, Hori M: Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation. 2002, 105 (4), S. 509-15.

34. Ichikawa K, Hashizume K: Thyroid hormone action in the cell. Endocr J. 1995, 42 (2), S. 131-40.

35. Ito H, Adachi S, Tamamori M, Fujisaki H, Tanaka M, Lin M, Akimoto H, Marumo F, Hiroe M: Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism. J Mol Cell Cardiol. 1996, 28 (6), S. 1271-7.

36. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Murumo F, Hiroe M: Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993, 92 (1), S. 398-403.

[Seite 98↓]

37. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A, Marumo F: Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 1993, 87 (5), S. 1715-21.

38. Izumo S, Nadal-Ginard B, Mahdavi V: Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci. 1988, 85 (2), S. 339-43.

39. Jaken S: Protein kinase C isozymes and substrates. Curr Opin Cell Biol. 1996, 8 (2), S. 168-73.

40. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. Biol Chem. 1995, 270 (28), S. 16483-6.

41. Karin M, Liu Z, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol. 1997, 9 (2), S. 240-6.

42. Kim NN, Villarreal FJ, Printz MP, Lee AA, Dillmann WH: Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. Am J Physiol. 1995, 269 (3 Pt 1), S. E426-37.

43. Kisselev AF, Akopian TN, Woo KM, Goldberg AL: The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem. 1999, 274 (6), S. 3363-71.

44. Kisselev AF, Goldberg AL: Proteasome inhibitors: from research tools to drug candidates. Chem Biol. 2001, 8 (8), S. 739-58.

45. Koepp DM, Harper JW, Elledge SJ: How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell. 1999, 97 (4), S. 431-4.

46. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR: Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature. 1993, 364 (6434), S. 249-52.

[Seite 99↓]

47. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y: Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. Possible role of protein kinase C activation. J Biol Chem. 1991, 266 (2), S. 1265-8.

48. Komuro I, Kurabayashi M, Takaku F, Yazaki Y: Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res. 1988, 62 (6), S. 1075-9.

49. Kopp F, Dahlmann B, Hendil KB: Evidence indicating that the human proteasome is a complex dimer. J Mol Biol. 1993, 229 (1), S. 14-9.

50. Lavandero S, Foncea R, Perez V, Sapag-Hagar M: Effect of inhibitors of signal transduction on IGF-1-induced protein synthesis associated with hypertrophy in cultured neonatal rat ventricular myocytes. FEBS Lett. 1998, 422 (2), S. 193-6.

51. Lee HR, Henderson SA, Reynolds R, Dunnmon P, Yuan D, Chien KR: Alpha 1-adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression. J Biol Chem. 1988, 263 (15), S. 7352-8.

52. Lerm M, Pop M, Fritz G, Aktories K, Schmidt G: Proteasomal degradation of cytotoxic necrotizing factor 1-activated rac. Infect Immun. 2002, 70 (8), S. 4053-8.

53. Liu ZP, Nakagawa O, Nakagawa M, Yanagisawa H, Passier R, Richardson JA, Srivastava D, Olson EN: CHAMP, a novel cardiac-specific helicase regulated by MEF2C. Dev Biol. 2001, 234 (2), S. 497-509.

54. Liu ZP, Olson EN: Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase. Proc Natl Acad Sci. 2002, 99 (4), S. 2043-8.

55. Long CS, Ordahl CP, Simpson PC: Alpha 1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. J Clin Invest. 1989, 83 (3), S. 1078-82.

[Seite 100↓]

56. Lopes UG, Erhardt P, Yao R, Cooper GM: p53-dependent induction of apoptosis by proteasome inhibitors. J Biol Chem. 1997, 272 (20), S. 12893-6.

57. Löwe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R: Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science. 1995, 268 (5210), S. 533-9.

58. Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA: Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol. 1998, 18 (2), S. 839-45.

59. Ma CP, Slaughter CA, DeMartino GN: Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem. 1992, 267 (15), S. 10515-23.

60. McDermott PJ, Morgan HE: Contraction modulates the capacity for protein synthesis during growth of neonatal heart cells in culture. Circ Res. 1989, 64 (3), S. 542-53.

61. Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY: Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J Biol Chem. 1998, 273 (11), S. 6373-9.

62. Messerli JM, Eppenberger-Eberhardt ME, Rutishauser BM, Schwarb P, von Arx P, Koch-Schneidemann S, Eppenberger HM, Perriard JC: Remodelling of cardiomyocyte cytoarchitecture visualized by three-dimensional (3D) confocal microscopy. Histochemistry. 1993, 100 (3), S. 193-202.

63. Mitch WE, Goldberg AL: Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996, 335 (25), S. 1897-905.

64. Morgan HE, Chua BHL, Russo L: Hrsg.: Fozzard et al.: The Heart. New York. Raven Press. 1992. S. 1505-1524.

65. Murakami K, Etlinger JD: Endogenous inhibitor of nonlysosomal high molecular weight protease and calcium-dependent protease. Proc Natl Acad Sci. 1986, 83 (20), S. 7588-92.

[Seite 101↓]

66. Musti AM, Treier M, Bohmann D: Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science. 1997, 275 (5298), S. 400-2.

67. Neer EJ: Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 1995, 80 (2), S. 249-57.

68. Ogawa Y, Itoh H, Nakagawa O, Shirakami G, Tamura N, Yoshimasa T, Nagata K, Yoshida N, Nakao K: Characterization of the 5'-flanking region and chromosomal assignment of the human brain natriuretic peptide gene. J Mol Med. 1995, 73 (9), S. 457-63.

69. Orlowski M: The multicatalytic proteinase complex, a major extralysosomal proteolytic system. Biochemistry. 1990, 29 (45), S. 10289-97.

70. Orlowski M, Cardozo C, Michaud C: Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry. 1993, 32 (6), S. 1563-72.

71. Orlowski RZ, Small GW, Shi YY: Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis. J Biol Chem. 2002, 277 (31), S. 27864-71.

72. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995, 269 (5224), S. 631-2.

73. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999, 18 (49), S. 6853-66.

74. Palmer JN, Hartogensis WE, Patten M, Fortuin FD, Long CS: Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest. 1995, 95 (6), S. 2555-64.

[Seite 102↓]

75. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T: The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 1994, 78 (5), S. 773-85.

76. Parker TG, Packer SE, Schneider MD: Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 1990, 85 (2), S. 507-14.

77. Piechaczyk M, Blanchard JM: c-fos proto-oncogene regulation and function. Crit Rev Oncol Hematol. 1994, 17 (2), S. 93-131.

78. Pinson A, Schluter KD, Zhou XJ, Schwartz P, Kessler-Icekson G, Piper HM: Alpha- and beta-adrenergic stimulation of protein synthesis in cultured adult ventricular cardiomyocytes. J Mol Cell Cardiol. 1993, 25 (4), S. 477-90.

79. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A: Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci. 2001, 98 (12), S. 6668-73.

80. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T: The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 1995, 2 (5), S. 493-506.

81. Riede UN, Schaefer HE: Subletale Zellschädigung. Hrsg.: Riede UN, Schaefer HE: Allgemeine und spezielle Pathologie. 4. Auflage. Stuttgart, New York. Thieme. 1999. S. 128ff.

82. Rivett AJ: The multicatalytic proteinase. Multiple proteolytic activities. J Biol Chem. 1989, 264 (21), S. 12215-9.

83. Rock KL, Goldberg AL: Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol. 1999, 17, S. 739-79.

84. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994, 78 (5), S. 767-71.

[Seite 103↓]

85. Rothwarf DM, Karin M: The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE. 1999, 1999 (5), S. RE1.

86. Rupp H, Berger HJ, Pfeifer A, Werdan K: Effect of positive inotropic agents on myosin isozyme population and mechanical activity of cultured rat heart myocytes. Circ Res. 1991, 68 (4), S. 1164-73.

87. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993, 75 (5), S. 977-87.

88. Salghetti SE, Muratani M, Wijnen H, Futcher B, Tansey WP: Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc Natl Acad Sci. 2000, 97 (7), S. 3118-23.

89. Schaub MC, Hefti MA, Harder BA, Eppenberger HM: Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med. 1997, 75 (11-12), S. 901-20.

90. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR: Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 2000, 404 (6779), S. 709-10.

91. Siehl D, Chua BH, Lautensack-Belser N, Morgan HE: Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart. Am J Physiol. 1985, 248 (3 Pt 1), S. C309-19.

92. Simpson P, Savion S: Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ Res. 1982, 50 (1), S. 101-16.

93. Simpson PC, Long CS, Waspe LE, Henrich CJ, Ordahl CP: Transcription of early developmental isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1989, Suppl 5, S. 79-89.

[Seite 104↓]

94. Smeal T, Hibi M, Karin M: Altering the specificity of signal transduction cascades: positive regulation of c-Jun transcriptional activity by protein kinase A. EMBO J. 1994, 13 (24), S. 6006-10.

95. Stack JH, Whitney M, Rodems SM, Pollok BA: A ubiquitin-based tagging system for controlled modulation of protein stability. Nat Biotechnol. 2000, 18 (12), S. 1298-302.

96. Stangl K, Gunther C, Frank T, Lorenz M, Meiners S, Ropke T, Stelter L, Moobed M, Baumann G, Kloetzel PM, Stangl V: Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem Biophys Res Commun. 2002, 291 (3), S. 542-9.

97. Stefanovsky VY, Pelletier G, Hannan R, Gagnon-Kugler T, Rothblum LI, Moss T: An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol Cell. 2001, 8 (5), S. 1063-73.

98. Sugden PH, Bogoyevitch MA: Endothelin-1-dependent signaling pathways in the myocardium. Trends Cardiovasc Med. 1996, 6, S. 87-94.

99. Sugden PH, Clerk A: Cellular mechanisms of cardiac hypertrophy. J Mol Med. 1998, 76 (11), S. 725-46.

100. Sugden PH, Fuller SJ: Regulation of protein turnover in skeletal and cardiac muscle. Biochem J. 1991, 273 (1), S. 21-37.

101. Swynghedauw B: Cardiac hypertrophy and failure. London, Paris. John Libbey Eurotext. 1990. S. 1-696.

102. Tanahashi N, Murakami Y, Minami Y, Shimbara N, Hendil KB, Tanaka K.: Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem. 2000, 275 (19), S. 14336-45.

103. Tanaka K: Molecular biology of proteasomes. Mol Biol Rep. 1995, 21 (1), S. 21-6.

[Seite 105↓]

104. Tapon N, Hall A: Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol. 1997, 9 (1), S. 86-92.

105. Terzic A, Puceat M, Vassort G, Vogel SM: Cardiac alpha 1-adrenoceptors: an overview. Pharmacol Rev. 1993, 45 (2), S. 147-75.

106. Thomas D, Tyers M: Transcriptional regulation: Kamikaze activators. Curr Biol. 2000, 10 (9), S. R341-3.

107. Treier M, Staszewski LM, Bohmann D: Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell. 1994, 78 (5), S. 787-98.

108. Tsubuki S, Saito Y, Kawashima S: Purification and characterization of an endogenous inhibitor specific to the Z-Leu-Leu-Leu-MCA degrading activity in proteasome and its identification as heat-shock protein 90. FEBS Lett. 1994, 344 (2-3), S. 229-33.

109. Tsubuki S, Saito Y, Tomioka M, Ito H, Kawashima S: Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem. 1996, 119 (3), S. 572-6.

110. Tsurumi C, Ishida N, Tamura T, Kakizuka A, Nishida E, Okumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N, et al: Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol Cell Biol. 1995, 15 (10), S. 5682-7.

111. van Bilsen M: Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system. Cardiovasc Res. 1997, 36 (3), S. 310-22.

112. van Bilsen M, Chien KR: Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res. 1993, 27 (7), S. 1140-9.

113. van Dam H, Duyndam M, Rottier R, Bosch A, de Vries-Smits L, Herrlich P, Zantema A, Angel P, van der Eb AJ: Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 1993, 12 (2), S. 479-87.

[Seite 106↓]

114. van Nocker S, Deveraux Q, Rechsteiner M, Vierstra RD: Arabidopsis MBP1 gene encodes a conserved ubiquitin recognition component of the 26S proteasome. Proc Natl Acad Sci. 1996, 93 (2), S. 856-60.

115. Vinitsky A, Michaud C, Powers JC, Orlowski M: Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry. 1992, 31 (39), S. 9421-8.

116. Voges D, Zwickl P, Baumeister W: The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem. 1999, 68, S. 1015-68.

117. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR: Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 1996, 271 (16), S. 9535-45.

118. Xu Y, Hopfner RL, McNeill JR, Gopalakrishnan V: Vasopressin accelerates protein synthesis in neonatal rat cardiomyocytes. Mol Cell Biochem. 1999, 195 (1-2), S. 183-90.

119. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM: Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996, 28 (6), S. 988-94.

120. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y: Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996, 271 (6), S. 3221-8.

121. Yamazaki T, Komuro I, Zou Y, Kudoh S, Mizuno T, Hiroi Y, Shiojima I, Takano H, Kinugawa K, Kohmoto O, Takahashi T, Yazaki Y: Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat cardiomyocytes. J Mol Cell Cardiol. 1997, 29 (9), S. 2491-501.

[Seite 107↓]

122. Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, Kreutz R, Wang Y, Maleeff B, Parsons AA, Ohlstein EH: Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem. 2000, 275 (48), S. 37895-901.

123. Zimmermann J, Erdmann D, Lalande I, Grossenbacher R, Noorani M, Furst P: Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1. Oncogene. 2000, 19 (25), S. 2913-20.

124. Zwickl P, Grziwa A, Puhler G, Dahlmann B, Lottspeich F, Baumeister W: Primary structure of the Thermoplasma proteasome and its implications for the structure, function, and evolution of the multicatalytic proteinase. Biochemistry. 1992, 31 (4), S. 964-72.

125. Zwickl P, Kleinz J, Baumeister W: Critical elements in proteasome assembly. Nat Struct Biol. 1994, 1 (11), S. 765-70.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: